Susan M Abdel-Rahman
Overview
Explore the profile of Susan M Abdel-Rahman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
1622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdel-Rahman S, Farrell A, Berry N, Burckart G
Clin Pharmacol Ther
. 2024 Apr;
116(3):511-514.
PMID: 38618676
No abstract available.
2.
Feldman K, Kearns G, Pearce R, Abdel-Rahman S, Leeder J, Friesen A, et al.
Clin Transl Sci
. 2022 Jan;
15(5):1155-1166.
PMID: 35099109
The C-pantoprazole breath test (PAN-BT) is a safe, noninvasive, in vivo CYP2C19 phenotyping probe for adults. Our objective was to evaluate PAN-BT performance in children, with a focus on discriminating...
3.
Thapa S, Luna R, Chumpitazi B, Oezguen N, Abdel-Rahman S, Garg U, et al.
Clin Transl Sci
. 2022 Jan;
15(4):1036-1049.
PMID: 35048535
Peppermint oil (PMO) is effective in the treatment of functional abdominal pain disorders, but its mechanism of action is unclear. Evidence suggests PMO has microbicidal activity. We investigated the effect...
4.
Gerding A, Swan S, Brayer K, Abdel-Rahman S
Clin Pharmacol Ther
. 2021 Sep;
110(4):841-844.
PMID: 34536015
No abstract available.
5.
Shulman R, Chumpitazi B, Abdel-Rahman S, Garg U, Musaad S, Kearns G
Br J Clin Pharmacol
. 2021 Sep;
88(3):1321-1333.
PMID: 34528282
Aims: Little is known regarding the pharmacokinetics and pharmacodynamics of menthol, the active ingredient in peppermint oil (PMO). Our aim was to investigate the pharmacokinetics of menthol at 3 dose...
6.
Stancil S, Mirzayev F, Abdel-Rahman S
Drug Des Devel Ther
. 2021 Jul;
15:2815-2830.
PMID: 34234413
Tuberculosis (TB) is the most deadly infectious disease globally. Although most individuals achieve a cure, a substantial portion develop multi-drug resistant TB which is exceedingly difficult to treat, and the...
7.
Abdel-Rahman S, Wimes M, Curran T
Clin Transl Sci
. 2021 Jun;
14(6):2095-2098.
PMID: 34191409
Individuals who identify as Black, indigenous, and people of color face well-documented health disparities. A root cause is the lack of empiric evidence for or against the use of various...
8.
Abdel-Rahman S, Paul I, Hornik C, Sullivan J, Wade K, Delmore P, et al.
Pediatrics
. 2021 Apr;
147(5).
PMID: 33846237
Background And Objectives: The Best Pharmaceuticals for Children Act (BPCA) incentivizes the study of on-patent medicines in children and mandates that the National Institutes of Health sponsor research on off-patent...
9.
Abdel-Rahman S, Bai S, Porter-Gill P, Goode G, Kearns G
Paediatr Drugs
. 2020 Nov;
23(1):95-104.
PMID: 33236188
Background: Medication refusal in children is largely driven by aversive taste profiles, which in turn influence adherence and therapeutic outcomes. However, there are no standardized methods for evaluating taste in...
10.
Abdel-Rahman S, Gill H, Carpenter S, Gueye P, Wicklund B, Breitkreutz M, et al.
Appl Clin Inform
. 2020 Apr;
11(2):253-264.
PMID: 32268389
Background: With the consequences of inadequate dosing ranging from increased bleeding risk to excessive drug costs and undesirable administration regimens, the antihemophilic factors are uniquely suited to dose individualization. However,...